Concepedia
Statistics
Publications
14
Citations
447
H-Index
13
Active since
1996
Affiliations
Novo Nordisk (Denmark)(Current)
Novo Nordisk (United States)
Rutgers New Jersey Medical School
Duke Medical Center
University of Copenhagen
Eva H. N. Olsen is an author at Novo Nordisk (Denmark) specializing in medicine, pharmacology, and hemostasis.
Publications per year
1996–2024
A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models
Henning R. Stennicke, Marianne Kjalke, Ditte M. Karpf et al. · Blood · 2013 · 115 citations · Full text
Medicine, Hematology, Pharmacology +2
Analysis of Functional Domain Organization in DNA Topoisomerase II from Humans and <i>Saccharomyces cerevisiae</i>
Sanne Jensen, Anni H. Andersen, Eigil Kjeldsen et al. · Molecular and Cellular Biology · 1996 · 48 citations · Full text
Life Sciences, Genetics, Molecular Biology +8
Comparative response of plasma VWF in dogs to up-regulation of VWF mRNA by interleukin-11 versus Weibel-Palade body release by desmopressin (DDAVP)
Eva H. N. Olsen, Arlene S. McCain, Elizabeth P. Merricks et al. · Blood · 2003 · 40 citations
Life Sciences, Immunology, Cell Signaling +8
Reduced bleeding events with subcutaneous administration of recombinant human factor IX in immune-tolerant hemophilia B dogs
Karen E. Russell, Eva H. N. Olsen, Robin A. Raymer et al. · Blood · 2003 · 39 citations · Full text
Medicine, Hematology, Immunology +16
Serological biomarkers detect active joint destruction and inflammation in patients with haemophilic arthropathy
Baolai Hua, Eva H. N. Olsen, Shu Sun et al. · Haemophilia · 2017 · 29 citations
Medicine, Pathobiology, Pathology +16
1–5 of 14